RE:RE:RE:RE:AstraZeneca's ADC disappoints - on severe adverse eventsFurther ot Fiercebiotech - Pfizer and Seagen announced their proposed merger on March 12. Then on May 12, each filed notifications with the FTC and the Department of Justice. Four days later, the FTC filed its suit in federal court to halt the proposed merger between Amgen and Horizon. The move was the first by the FTC in more than a decade against a pharma M&A deal.
A month later, on June 14, 2023, Pfizer withdrew its notification for its proposed $43 billion acquisition of cancer drug specialist Seagen, stating that it would submit another notification later on the same day. No such notification has been filed thus far.
https://www.fiercepharma.com/pharma/ftc-eyeing-deal-pfizer-refiles-notification-43b-buyout-seagen
https://d18rn0p25nwr6d.cloudfront.net/CIK-0001060736/4e87c484-76b7-43f1-97a4-f789baa3cc58.pdf